HY-148530-10mg
|
MedChemexpress LLC
|
YX-2-107 [CAS 2417408-46-7]
|
|
Cancer-Kinase/protease
|
|
HY-148530-25mg
|
MedChemexpress LLC
|
YX-2-107 [CAS 2417408-46-7]
|
|
Cancer-Kinase/protease
|
|
HY-148530-5mg
|
MedChemexpress LLC
|
YX-2-107 [CAS 2417408-46-7]
|
|
Cancer-Kinase/protease
|
|
HY-148530-50mg
|
MedChemexpress LLC
|
YX-2-107 [CAS 2417408-46-7]
|
|
Cancer-Kinase/protease
|
|
HY-148530-1mL
|
MedChemexpress LLC
|
YX-2-107 [CAS 2417408-46-7] (10mM in DMSO)
|
|
Cancer-Kinase/protease
|
|
HY-19359-1mg
|
MedChemexpress LLC
|
ZED-1227 [CAS 1542132-88-6]
|
|
COVID-19-immunoregulation
|
|
HY-19359-10mg
|
MedChemexpress LLC
|
ZED-1227 [CAS 1542132-88-6]
|
|
COVID-19-immunoregulation
|
|
HY-19359-100mg
|
MedChemexpress LLC
|
ZED-1227 [CAS 1542132-88-6]
|
|
COVID-19-immunoregulation
|
|
HY-19359-5mg
|
MedChemexpress LLC
|
ZED-1227 [CAS 1542132-88-6]
|
|
COVID-19-immunoregulation
|
|
HY-19359-50mg
|
MedChemexpress LLC
|
ZED-1227 [CAS 1542132-88-6]
|
|
COVID-19-immunoregulation
|
|
HY-B0124-200mg
|
MedChemexpress LLC
|
Zonisamide [CAS 68291-97-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0124-500mg
|
MedChemexpress LLC
|
Zonisamide [CAS 68291-97-4]
|
|
Neuroscience-Neurodegeneration
|
|
HY-B0124-1mL
|
MedChemexpress LLC
|
Zonisamide [CAS 68291-97-4] (10mM in DMSO)
|
|
Neuroscience-Neurodegeneration
|
|